Morcellator Lawsuit Settlement Funding and Lawsuit Help
Legal-Bay is a leader in Morcellator pre-settlement lawsuit funding and can also assist you with help in finding a Morcellator law firm or Morcellator lawyer if you are unsure whether or not you have a potential claim against Johnson and Johnson or any other manufacturers.
Laparoscopic Power Morcellators and Possible Uterine Cancer
Power morcellators were initially approved in 1993 by the U.S. Food and Drug Administration (FDA). Power morcellators have been used in different laparoscopic surgeries including hysterectomy and myomectomy procedures as well as laparoscopic spleen and renal surgeries. In July of 2014, the FDA concluded that the risk for spreading cancer is 1 in 350. Due to the discovery that the device may actually spread cancerous tissue, the FDA recommended that doctors stop using them.
FDA Warnings and Possible Side Effects
In April of 2014, the FDA issued a warning letter stating that the use of power morcellators may actually spread cancers when being used to remove fibroid tumors. After the warning letter came out, Johnson & Johnson suspended additional sales of three Ethicon power morcellator device models.
In July of 2014, the FDA’s Medical Devices Advisory Committee held a meeting to highlight the problems associated with the devices. Morcellation devices may actually disseminate malignant tissue, and the FDA concluded that the risk for spreading cancer is 1 in 350. Due to the discovery that the device may actually spread cancerous tissue, the FDA recommended that doctors stop using them. The FDA also concluded that surgeons who do use power morcellators should inform patients of the risks of the use of the devices. They also suggested serious warning statements should be added to product packaging, and recommended increasing the device classification to the higher Class II category. An FDA Class II recall typically indicates that a device may cause “temporary or medically reversible” health problems, as well as a remote possibility of serious health problems.
Also in July of 2014, Johnson & Johnson issued a voluntary recall of the following three laparoscopic power morcellators from hospitals worldwide: the Gynecare Morcellex, the Morcellex Sigma, and the Gynecare X-Tract.
Morcellation devices are used during several medical procedures. While the morcellator device provides a less-invasive surgery and quicker recovery time, the following have been listed as potential side effects:
- Spread of malignant tissue
- Advanced-stage cancerous growths
- Metastatic leiomyosarcoma, an aggressive uterine cancer
With as many as 50,000 surgeries a year involving morcellation of fibroids, Johnson & Johnson is a market leader in morcellation device sales. Several lawsuits have already been filed against Johnson & Johnson relating to the power morcellation devices. Among those who have already filed are patients who were diagnosed with advanced stage cancer following the procedure with the morcellation device. Johnson & Johnson is also facing thousands of lawsuits over their faulty hip and pelvic mesh devices.
Morcellator Wrongful Death Suit Settlement
This summer, LiNA Medical settled a case against them for an undisclosed amount over a power morcellator death case. The company settled the case before it even went to trial, and there are approximately 20 other morcellator lawsuits at this time. According to Drug Watch, the company did not comment on the settlement.
This case was one of the first laparoscopic power morcellator lawsuits filed in federal court, and according to the U.S. FDA, as many as 1 in 350 women are “suspected of having undiagnosed uterine sarcoma that may be spread during morcellation.” The victim’s husband filed the suit, stating she had no evidence of cancer or disease prior to her surgery in March of 2012, however, about a week after she had the procedure, doctors told her she had cancer, and she died at 53 – only 11 months after the surgery.
Get the help you need on your Morcellator Lawsuit Claim
If you, or a loved one, have already filed a Morcellator lawsuit and need a pre-settlement cash advance on your lawsuit to assist you in this time of need, feel free to fill out the application on the upper left hand side of this page. To speak to a live agent right now, call our toll free hotline at: 877.571.0405 where agents are always standing by to answer any questions you may have regarding Morcellator lawsuit funding.
If you’re unsure whether or not you have a potential lawsuit claim regarding a morcellaton device or a hospital and you’d like to speak with a nationally recognized Morcellator lawyer, fill out the application on the upper right hand part of this page or call our toll-free hotline at: 877.571.0405 where live agents can assist you with any lawsuit services that you may need.
1. The minimum payback period is 6 months – We do not invest in cases with payback periods of less than 6 months. Our maximum APR on a 6 month lawsuit settlement funding payback, including all fees, is 29% annually.
2. The maximum payback period is 36 months – We do not charge usage fees past 3 years, which means you will not be charged any additional money past 36 months. However, if your case does not settle within 36 months you are not obliged to repay us until it officially does. Our maximum APR on a 36 month lawsuit settlement funding payback, including all fees, is 25% annually.
3. CLICK HERE to view example of cost of funding, including all fees, and final payback on a lawsuit settlement funding